Tumor necrosis factor-α and Muc2 mucin play major roles in disease onset and progression in dextran sodium sulphate-induced colitis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Dharmani, Poonam ^a   Leung, Pearl ^a   Chadee, Kris ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MUCIN 2; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA; MUC2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; GOBLET CELL; HISTOLOGY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; RECTUM HEMORRHAGE; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COLITIS; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

RATTUS;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; COLITIS; DEXTRAN SULFATE; DISEASE PROGRESSION; EPITHELIAL CELLS; GOBLET CELLS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-10; MALE; MUCIN-2; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052872019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025058     Document Type: Article

References (29)

1. Dharmani P, Chadee K, (2008) Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 1: 195-212.
2. Hendrickson BA, Gokhale R, Cho JH, (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15: 79-94.
3. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, et al. (2009) Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 4: e6073.
4. Renes IB, Boshuizen JA, Van Nispen DJ, Bulsing NP, Buller HA, et al. (2002) Alterations in Muc2 biosynthesis and secretion during dextran sulfate sodium-induced colitis. Am J Physiol Gastrointest Liver Physiol 282: G382-389.
5. Baumgart DC, Sandborn WJ, (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657.
6. Dieleman LA, Pena AS, Meuwissen SG, van Rees EP, (1997) Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl 223: 99-104.
7. Moncada DM, Kammanadiminti SJ, Chadee K, (2003) Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol 19: 305-311.
8. Clayburgh DR, Shen L, Turner JR, (2004) A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 84: 282-291.
9. Toshina K, Hirata I, Maemura K, Sasaki S, Murano M, et al. (2000) Enprostil, a prostaglandin-E(2) analogue, inhibits interleukin-8 production of human colonic epithelial cell lines. Scand J Immunol 52: 570-575.
10. Xu Y, Hunt NH, Bao S, (2007) The correlation between pro-inflammatory cytokines, MAdCAM-1 and cellular infiltration in the inflamed colon from TNF-alpha gene knockout mice. Immunol Cell Biol 85: 633-639.
11. Dharmani P, Srivastava V, Kissoon-Singh V, Chadee K, (2009) Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun 1: 123-135.
12. Andrianifahanana M, Moniaux N, Batra SK, (2006) Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 1765: 189-222.
13. Shekels LL, Anway RE, Lin J, Kennedy MW, Garside P, et al. (2001) Coordinated Muc2 and Muc3 mucin gene expression in Trichinella spiralis infection in wild-type and cytokine-deficient mice. Dig Dis Sci 46: 1757-1764.
14. Enss ML, Cornberg M, Wagner S, Gebert A, Henrichs M, et al. (2000) Pro-inflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res 49: 162-169.
15. Iwashita J, Sato Y, Sugaya H, Takahashi N, Sasaki H, et al. (2003) mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol 81: 275-282.
16. Kim YD, Jeon JY, Woo HJ, Lee JC, Chung JH, et al. (2002) Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PI3K in human airway epithelial cells. J Korean Med Sci 17: 765-771.
17. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, et al. (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-992.
18. Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, et al. (2001) Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49: 190-198.
19. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W, (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
20. Soderholm JD, Olaison G, Peterson KH, Franzen LE, Lindmark T, et al. (2002) Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 50: 307-313.
21. Sun Y, Fihn BM, Sjovall H, Jodal M, (2004) Enteric neurones modulate the colonic permeability response to luminal bile acids in rat colon in vivo. Gut 53: 362-367.
22. Cario E, Podolsky DK, (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010-7017.
23. Charo IF, Ransohoff RM, (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621.
24. Goebel S, Huang M, Davis WC, Jennings M, Siahaan TJ, et al. (2006) VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 290: G648-654.
25. Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, et al. (2001) Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 299: 442-448.
26. Leeb SN, Vogl D, Gunckel M, Kiessling S, Falk W, et al. (2003) Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology 125: 1341-1354.
27. Hogan SP, Seidu L, Blanchard C, Groschwitz K, Mishra A, et al. (2006) Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 118: 257-268.
28. Chadee K, Keller K, Forstner J, Innes DJ, Ravdin JI, (1991) Mucin and nonmucin secretagogue activity of Entamoeba histolytica and cholera toxin in rat colon. Gastroenterology 100: 986-997.
29. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.